LifePearl-Doxo Pharmacokinetic (PK) Study

NCT02548780 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

HCC
Hepatocellular Carcinoma

Interventions

DEVICE: Chemoembolization
OTHER: Pharmacokinetics

Sponsor

Terumo Europe N.V.

Collaborators

[object Object]
[object Object]